Evidence map›Paper›PMID 30542553›Full record

ArticleChemical science2018

Advanced microRNA-based cancer diagnostics using amplified time-gated FRET.

Xue Qiu, Jingyue Xu, Jiajia Guo, Akram Yahia-Ammar, Nikiforos-Ioannis Kapetanakis, Isabelle Duroux-Richard, Julia J Unterluggauer, Nicole Golob-Schwarzl, Christophe Regeard, Catherine Uzan and 6 more

Abstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xue QiuNanoBioPhotonics , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France . Email: niko.hildebrandt@u-psud.fr ; https://www.nanofret.com.
Jingyue XuNanoBioPhotonics , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France . Email: niko.hildebrandt@u-psud.fr ; https://www.nanofret.com.
Jiajia GuoNanoBioPhotonics , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France . Email: niko.hildebrandt@u-psud.fr ; https://www.nanofret.com.
Akram Yahia-AmmarNanoBioPhotonics , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France . Email: niko.hildebrandt@u-psud.fr ; https://www.nanofret.com.
Nikiforos-Ioannis KapetanakisGustave Roussy , Université Paris-Saclay , CNRS , UMR 8126 , Villejuif , France.ORCID 0000-0001-6423-201X
Isabelle Duroux-RichardIRMB , INSERM , Univ Montpellier , Montpellier , France.
Julia J UnterluggauerDiagnostic and Research Institute of Pathology , Diagnostic and Research Center for Molecular BioMedicine , Medical University of Graz , Austria.
Nicole Golob-SchwarzlDiagnostic and Research Institute of Pathology , Diagnostic and Research Center for Molecular BioMedicine , Medical University of Graz , Austria.
Christophe RegeardLaboratoire de Génomique et Biodiversité Microbienne des Biofilms (LGBMB) , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France.
Catherine UzanDepartment of Surgery , Gustave Roussy , Université Paris-Saclay , Villejuif , France.
Sébastien GouyDepartment of Surgery , Gustave Roussy , Université Paris-Saclay , Villejuif , France.
Michael DuBowLaboratoire de Génomique et Biodiversité Microbienne des Biofilms (LGBMB) , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France.ORCID 0000-0001-7539-9288
Johannes HaybaeckDiagnostic and Research Institute of Pathology , Diagnostic and Research Center for Molecular BioMedicine , Medical University of Graz , Austria.
Florence ApparaillyIRMB , INSERM , Univ Montpellier , Montpellier , France.ORCID 0000-0003-1762-084X
Pierre BussonGustave Roussy , Université Paris-Saclay , CNRS , UMR 8126 , Villejuif , France.ORCID 0000-0003-1027-3400
Niko HildebrandtNanoBioPhotonics , Institute for Integrative Biology of the Cell (I2BC) , Université Paris-Saclay , Université Paris-Sud , CNRS , CEA , Orsay , France . Email: niko.hildebrandt@u-psud.fr ; https://www.nanofret.com.ORCID 0000-0001-8767-9623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) play an important role in cellular functions and in the development and progression of cancer. Precise quantification of endogenous miRNAs from different clinical patient and control samples combined with a one-to-one comparison to standard technologies is a challenging but necessary endeavor that is largely neglected by many emerging fluorescence technologies. Here, we present a simple, precise, sensitive, and specific ratiometric assay for absolute quantification of miRNAs. Isothermally amplified time-gated Förster resonance energy transfer (TG-FRET) between Tb donors and dye acceptors resulted in miRNA assays with single-nucleotide variant specificity and detection limits down to 4.2 ± 0.5 attomoles. Quantification of miR-21 from human tissues and plasma samples revealed the relevance for breast and ovarian cancer diagnostics. Analysis of miR-132 and miR-146a from acute monocytic leukemia cells (THP-1) demonstrated the broad applicability to different miRNAs and other types of clinical samples. Direct comparison to the gold standard RT-qPCR showed advantages of amplified TG-FRET concerning precision and specificity when quantifying low concentrations of miRNAs as required for diagnostic applications. Our results demonstrate that a careful implementation of rolling circle amplification and TG-FRET into one straightforward nucleic acid detection method can significantly advance the possibilities of miRNA-based cancer diagnostics and research.

Identifiers

PMID30542553
PMCPMC6249629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.